| Literature DB >> 35628986 |
Lan Sook Chang1, Hyun Wang1, Hee Chang Ahn2, Tae Hyeon Lee1, Kyung Tae3, Seong Oh Park1.
Abstract
This study investigated the impact of postoperative radiotherapy (PORT) on dietary function in patients who underwent pharyngoesophageal defect reconstruction using a free jejunal flap. A retrospective chart review of 36 patients who underwent circumferential pharyngoesophageal defect reconstruction using a free jejunal flap was performed. The European Organization for the Research and Treatment of Cancer head and neck cancer module questionnaire was used. Five items related to dietary function were selected and analyzed for changes in scores before and after PORT. Both the PORT and non-PORT groups showed improved dietary function before surgery, and no significant changes were noted at 3 and 12 months postoperatively. Repeated measures ANOVA showed that PORT had no significant impact on dietary function. In univariate analysis, no variable was a significant predictor of the score at 12 months, postoperatively. Previous radiotherapy and neck dissection had a close statistically significant relation. The multivariate analysis showed that neoadjuvant chemotherapy, previous radiotherapy, and neck dissection were significant predictors of the score at 12 months, postoperatively. PORT did not show a significant effect on the 12 months postoperative score. Free jejunal flap is an effective pharyngoesophageal defect reconstruction method that does not cause any dietary function disruption after PORT.Entities:
Keywords: PORT; dietary function; dysphagia; jejunal flap; pharyngoesophageal reconstruction
Year: 2022 PMID: 35628986 PMCID: PMC9144676 DOI: 10.3390/jcm11102860
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Five selected items related to dietary function from the European Organization for Research and Treatment of Cancer (EORTC) head and neck cancer module (QLQ-H&N35) [6].
| During the Past Week | Not at All | A Little | Quite a Bit | Very Much |
|---|---|---|---|---|
| Have you had a painful throat? | 1 | 2 | 3 | 4 |
| Have you had problems swallowing liquids? | 1 | 2 | 3 | 4 |
| Have you had problems swallowing pureed food? | 1 | 2 | 3 | 4 |
| Have you had problems swallowing solid food? | 1 | 2 | 3 | 4 |
| Have you had trouble eating? | 1 | 2 | 3 | 4 |
Baseline characteristics of the study population.
| Baseline Characteristics | Value | PORT+ | PORT− | |
|---|---|---|---|---|
| Number | 36 | 22 (61.1) | 14 (38.9) | |
| Age at op (yr) | 55.22 ± 9.97 | 54.91 ± 10.94 | 55.71 ± 8.60 | 0.817 |
| Sex | 0.511 | |||
| Male | 34 (94.4) | 20 (90.9) | 14 (100) | |
| Female | 2 (5.5) | 2 (9.1) | 0 (0) | |
| Follow-up period (mo) | 49.47 ± 28.65 | |||
| Cancer type | 0.754 | |||
| Hypopharyngeal cancer | 28 (77.8) | 17 (77.3) | 11 (78.6) | |
| Upper esophageal cancer | 4 (11.1) | 2 (9.1) | 2 (14.3) | |
| Laryngeal cancer | 4 (11.1) | 3 (13.6) | 1 (7.1) | |
| Primary or Recurred | 0.067 | |||
| Primary | 25 (69.4) | 18 (81.8) | 7 (50.0) | |
| Recurred | 11 (30.6) | 4 (18.2) | 7 (50.0) | |
| Neoadjuvant CTx | 11 (30.6) | 8 (36.4) | 3 (21.4) | 0.467 |
| Adjuvant CTx | 18 (50.0) | 16 (72.7) | 2 (14.3) | 0.001 |
| Previous RTx | 11 (30.6) | 5 (22.7) | 6 (42.9) | 0.273 |
| T stage | 0.105 | |||
| T1 | 1 (2.8) | 0 (0) | 1 (7.1) | |
| T2 | 5 (13.9) | 1 (4.5) | 4 (28.6) | |
| T3 | 7 (11.1) | 6 (27.3) | 1 (7.1) | |
| T4 | 23 (8.3) | 15 (68.2) | 8 (57.1) | |
| N stage | 0.216 | |||
| N0 | 18 (50.0) | 8 (36.4) | 10 (71.4) | |
| N1 | 11 (30.6) | 9 (40.9) | 2 (14.3) | |
| N2 | 4 (11.1) | 3 (13.6) | 1 (7.1) | |
| N3 | 3 (8.3) | 2 (9.1) | 1 (7.1) |
CTx, Chemotherapy; RTx, Radiotherapy.
Baseline characteristics of the study population.
| Operation Related | Value | PORT+ | PORT− | |
|---|---|---|---|---|
| Neck dissection | 0.04 | |||
| MRND | 18 (50) | 14 (63.6) | 4 (28.6) | |
| Selective neck dissection | 10 (27.8) | 6 (27.3) | 4 (28.6) | |
| Extended neck dissection | 3 (8.3) | 2 (9.1) | 1 (7.1) | |
| Other | 2 (5.5) | 0 (0) | 2 (14.3) | |
| None | 3 (8.3) | 0 (0) | 3 (21.4) | |
| Concomitant Thyroidectomy | 15 (41.7) | 8 (36.4) | 7 (50.0) | 0.499 |
| Length of jejunal FF | 15.58 ± 3.11 | 15.45 ± 2.79 | 15.79 ± 3.66 | 0.761 |
| Recipient artery | 1.000 | |||
| Sup. Thyroid artery | 32 (88.9) | 19 (86.4) | 13 (92.9) | |
| Other | 4 (11.1) | 3 (13.6) | 1 (7.1) | |
| Recipient vein | 1.000 | |||
| Ext. jugular vein | 25 (69.4) | 15 (68.2) | 10 (71.4) | |
| Branch of internal jugular vein | 8 (22.2) | 5 (22.7) | 3 (21.4) | |
| Vena comitantes of sup. thyroid artery | 3 (8.3) | 2 (9.1) | 1 (7.1) |
MRND, modified radical neck dissection.
Outcome variables evaluated.
| Variables | Value | PORT+ | PORT− | |
|---|---|---|---|---|
| Esophagography (days) | 18.81 ± 2.90 | 19.05 ± 3.06 | 18.43 ± 2.68 | 0.761 |
| Oral intake start (days) | 20.56 ± 4.63 | 21.05 ± 5.47 | 19.79 ± 2.89 | 1.000 |
| Early Complication | 1.000 | |||
| Leakage | 3 (7.5) | 2 (9.1) | 1 (7.1) | |
| Hematoma | 1 (2.5) | 0 (0) | 1 (7.1) | |
| Flap failure | 1 (2.5) | 1 (4.5) | 0 (0) | |
| Late complication | 1.000 | |||
| PEG insertion due to swallowing difficulty | 3 (7.5) | 2 (9.1) | 1 (7.1) | |
| Focal stenosis | 1 (2.5) | 0 (0) | 1 (7.1) | |
| Donor site complication | 1.000 | |||
| Wound dehiscence | 2 (5) | 1 (4.5) | 1 (7.1) | |
| Intussusception | 1 (2.5) | 0 (0) | 1 (7.1) |
PEG, percutaneous endoscopic gastrostomy.
Questionnaire findings and comparison between the groups.
| Variables | PORT− | PORT+ | Overall |
|---|---|---|---|
| Questionnaire score | |||
| Preop | 10.14 ± 3.21 | 11.86 ± 3.99 | 11.19 ± 3.76 |
| Postop 3 months | 9.21 ± 2.94 | 9.82 ± 3.22 | 9.58 ± 3.01 |
| Postop 12 months | 8.86 ± 3.35 | 9.82 ± 3.29 | 9.44 ± 3.30 |
| 0.310 † | |||
| Differences within groups with time ( | |||
† Statistically significant values.
Figure 1Questionnaire score of the two groups at different time points.
Univariate and multivariate analyses for predictors of dietary function.
| Variables | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| Coefficient | Coefficient | |||
| Age | 0.021 | 0.715 | −0.015 | 0.728 |
| Sex | 1.647 | 0.170 | 2.7764 | 0.170 |
| Cancer type | −0.155 | 0.959 | 0.074 | |
| Hypopharyngeal cancer | Ref | Ref | ||
| Upper esophageal cancer | 0 | 1 | −1.594 | 0.259 |
| Laryngeal cancer | −0.5 | 0.773 | −2.8434 | 0.081 |
| Recurred cancer | −1.033 | 0.395 | ||
| Length of jejunal FF | 0.223 | 0.218 | ||
| Neoadjuvant CTx | −0.407 | 0.738 | −2.9493 | 0.006 † |
| Previous RTx | 1.978 | 0.098 | 3.4673 | 0.002 † |
| Adjuvant CTx | 0.0111 | 0.405 | ||
| Postop RTx | 0.961 | 0.212 | 0.0648 | 0.962 |
| Early complication | −0.531 | 0.577 | ||
| Neck dissection | 0.623 | 0.069 | <0.001 | |
| None | Ref | Ref | ||
| MRND | 4.778 | 0.009 | 7.640 | <0.001 † |
| Selective neck dissection | 3.867 | 0.004 | 6.448 | 0.001 |
| Extended neck dissection | 3.333 | 0.162 | 2.934 | 0.182 |
| Other | 6.667 | 0.012 | 8.174 | <0.001 |
FF, free flap; CTx, chemotherapy; RTx, radiotherapy; Postop, postoperative; MRND, modified radical neck dissection. † Statistically significant values.